JA Solar to Host Fourth Quarter and Full Year 2016 Results Conference Call on March 16, 2017
Mar 02, 2017 12:01 pm UTC| Business
BEIJING, March 02, 2017 -- JA Solar Holdings Co., Ltd. (Nasdaq:JASO) ("JA Solar" or "JA"), one of the world's largest manufacturers of high-performance solar power products, today announced that it will report its...
JA Solar to Host Fourth Quarter and Full Year 2016 Results Conference Call on March 16, 2017
Mar 02, 2017 12:01 pm UTC| Business
BEIJING, March 02, 2017 -- JA Solar Holdings Co., Ltd. (Nasdaq:JASO) ("JA Solar" or "JA"), one of the world's largest manufacturers of high-performance solar power products, today announced that it will report its...
KVH Industries Reports Fourth Quarter and Full Year 2016 Results
Mar 02, 2017 12:01 pm UTC| Business
MIDDLETOWN, R.I., March 02, 2017 -- KVH Industries, Inc., (Nasdaq:KVHI) reported financial results for the fourth quarter and fiscal year ended December 31, 2016 today. The company will hold a conference call to discuss...
KVH Industries Reports Fourth Quarter and Full Year 2016 Results
Mar 02, 2017 12:01 pm UTC| Business
MIDDLETOWN, R.I., March 02, 2017 -- KVH Industries, Inc., (Nasdaq:KVHI) reported financial results for the fourth quarter and fiscal year ended December 31, 2016 today. The company will hold a conference call to discuss...
Chimerix Announces Fourth Quarter and Full Year 2016 Financial Results
Mar 02, 2017 12:01 pm UTC| Business
- Successful Administration of IV Brincidofovir 50 mg in Ongoing Dose Escalation Study - - Demonstrates Favorable Safety and Tolerability Profile -- Conference Call at 8:30 a.m. ET Today -DURHAM, N.C., March 02, 2017 --...
Chimerix Announces Fourth Quarter and Full Year 2016 Financial Results
Mar 02, 2017 12:01 pm UTC| Business
- Successful Administration of IV Brincidofovir 50 mg in Ongoing Dose Escalation Study - - Demonstrates Favorable Safety and Tolerability Profile -- Conference Call at 8:30 a.m. ET Today -DURHAM, N.C., March 02, 2017 --...
Recro Pharma to Present at Upcoming Investor Conferences
Mar 02, 2017 12:01 pm UTC| Business
MALVERN, Pa., March 02, 2017 -- Recro Pharma, Inc. (NASDAQ:REPH), a revenue generating specialty pharmaceutical company focused on products for hospital and ambulatory care settings, currently developing non-opioid...